Immunoglobulin G Glycosylation in Diseases (CROSBI ID 70925)
Prilog u knjizi | izvorni znanstveni rad
Podaci o odgovornosti
Marija Pezer
engleski
Immunoglobulin G Glycosylation in Diseases
Changes in immunoglobulin G (IgG) glycosylation pattern have been observed in a vast array of auto- and alloimmune, infectious, cardiometabolic, malignant, and other diseases. This chapter contains an updated catalog of over 140 studies within which IgG glycosylation analysis was performed in a disease setting. Since the composition of IgG glycans is known to modulate its effector functions, it is suggested that a changed IgG glycosylation pattern in patients might be involved in disease development and progression, representing a predisposition and/or a functional effector in disease pathology. In contrast to the glycopattern of bulk serum IgG, which likely relates to the systemic inflammatory background, the glycosylation profile of antigen- specific IgG probably plays a direct role in disease pathology in several infectious and allo- and autoimmune antibody-dependent diseases. Depending on the specifics of any given disease, IgG glycosylation read-out might therefore in the future be developed into a useful clinical biomarker, or a supplementary to currently used biomarkers.
IgG glycosylation ; differential glycosylation ; disease ; biomarker
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o prilogu
395-431.
objavljeno
10.1007/978-3-030-76912-3_13
Podaci o knjizi
Antibody Glycosylation
Pezer, Marija
Cham: Springer
2021.
978-3-030-76911-6